These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23455202)

  • 1. Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
    Ye L; Fu F; Liu W; Sun K; Li Y; He J; Yu X; Yu P; Tian J
    Pak J Pharm Sci; 2013 Mar; 26(2):315-22. PubMed ID: 23455202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies.
    Gao P; Xu H; Ding P; Gao Q; Sun J; Chen D
    Int J Pharm; 2007 Feb; 330(1-2):1-5. PubMed ID: 16987624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
    Chu DF; Fu XQ; Liu WH; Liu K; Li YX
    Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of injectable sustained-release microspheres of rivastigmine.
    Zhu Y; Zhu Z; Cao Q; Chen D; Cui J
    J Control Release; 2011 Nov; 152 Suppl 1():e131-2. PubMed ID: 22195801
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation and in vivo evaluation of huperzine A-loaded PLGA microspheres.
    Fu XD; Gao YL; Ping QN; Ren T
    Arch Pharm Res; 2005 Sep; 28(9):1092-6. PubMed ID: 16212243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
    Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B
    J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation.
    Wang W; Cai Y; Zhang G; Liu Y; Sui H; Park K; Wang H
    Drug Deliv; 2016 Nov; 23(9):3674-3680. PubMed ID: 27689622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dental resin as controlled release layer for the development of an innovative long-acting intra-oral delivery system.
    Liu H; Li X; Dave B; Hu L
    Eur J Pharm Sci; 2020 Feb; 143():105165. PubMed ID: 31765810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramizol
    Wright L; Rao S; Thomas N; Boulos RA; Prestidge CA
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1451-1457. PubMed ID: 29619851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective glucuronidation metabolism, pharmacokinetics, anti-amnesic pharmacodynamics, and toxic properties of vasicine enantiomers in vitro and in vivo.
    Zhu Y; Liu W; Qi S; Wang H; Wang Y; Deng G; Zhang Y; Li S; Ma C; Wang Y; Cheng X; Wang C
    Eur J Pharm Sci; 2018 Oct; 123():459-474. PubMed ID: 30077712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A.
    Patel PA; Patil SC; Kalaria DR; Kalia YN; Patravale VB
    Int J Pharm; 2013 Mar; 446(1-2):16-23. PubMed ID: 23410989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
    Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
    Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease.
    Liu WH; Song JL; Liu K; Chu DF; Li YX
    J Control Release; 2005 Oct; 107(3):417-27. PubMed ID: 16154224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.